This tissue paper is made from actual organ tissues

Northwestern University researchers have created biomaterials made from animal organs and tissues that could potentially support natural hormone production in young cancer patients and aid wound healing. The materials, aptly named tissue papers, are made from structural proteins that are excreted by cells and give organs their forms and structures. The tissue papers are thin and

ABL increases aseptic fill/finish capacity with automated vial filling line

ABL, a leading contract research, development and biomanufacturing organization to the biopharmaceutical industry worldwide, has announced the expansion of its aseptic fill/finish operations at its Rockville, Md. GMP biomanufacturing facility with the installation of a new, fully automated vial filling system. ABL’s new filling line was specifically selected by ABL to meet the needs of

Sepsis causes most hospital readmissions

A University of Pittsburgh School of Medicine and VA Pittsburgh Healthcare System analysis recently showed that sepsis results in more hospital readmissions and costs than any of the other 4 medical conditions that the government tracks for quality of care and guide pay-for-performance reimbursements. The results should provide food for thought for medical device developers

Medtech stories we missed this week: April 28, 2017

From FDA and Health Canada approvals to joint ventures, here are medtech stories we missed this week but thought were still worth mentioning. 1. FDA clears Joimax Endovapor 2 Joimax announced in an April 26 press release that it has received FDA 510(k) clearance to market its Endovapor 2 Multi-Radio Frequency System. The device generates

This test can detect tiny ovarian tumors sooner than current tests

Massachusetts Institute of Technology engineers have developed a way to detect ovarian tumors that are smaller than 2 mm in diameter, allowing for detection 5 months earlier than existing tests. A synthetic biomarker, which is a nanoparticle that works with tumor proteins to release fragments into the urine for detection, helps the MIT-developed test create

This molecule stops pancreatic cancer cells from spreading

Wake Forest Baptist Medical Center scientists have identified molecules that could be the next therapeutic solution for pancreatic cancer. Pancreatic cancer is one of the most lethal forms of cancer. About 53,670 people are expected to be diagnosed with pancreatic cancer this year with 43,090 dying from it, according to the American Cancer Society. The

Your brain doesn’t navigate like a GPS after all

Neurons were once considered the brain’s GPS, and they were subject of a Nobel Prize in 2014 that outlined the discovery of grid cells and specialized neurons that help animals keep track of their location in environments. New Stanford University research suggests that the brain and neurons just might be more complex than that. Lisa

How the CellMist SkinGun heals: a Q&A with RenovaCare’s CEO

When Thomas Bold joined RenovaCare in 2013, he was already familiar with its potentially groundbreaking technology. Bold had served as StemCell Systems CEO in Berlin for many years. He was involved in the development of the CellMist and SkinGun – the platform technologies for RenovaCare Inc. The technologies represent a shift in thinking about wound care, Bold said. Bold’s goal

This contact lenses breakthrough could enable glucose monitoring

Biosensing contact lenses may not be able to self-heal like “The Terminator,” but they could measure blood glucose and detect other signs of disease in the future. Oregon State University researchers are set to present a study that suggests transparent biosensors that are embedded into contact lenses could provide insight for doctors and patients without

Solar powered skin could make prosthetics better: Here’s how

University of Glasgow engineers are using the sun to power artificial skin and return a sense of touch in amputees with prosthetics. The engineers previously developed an electronic skin made of graphene that covered prosthetic hands. They’re now using the unique properties of graphene to power new artificial skin. Graphene is a single-atom thick material

This is not a test: RMAT designation goes live

By: Peter Marks, M.D., Ph.D. The field of regenerative medicine encompasses a wide scope of innovative products including cell therapies, therapeutic tissue engineering products, human cell and tissue products, and certain combination products using such therapies. Examples include genetically-modified cellular therapies, such as chimeric antigen receptor T-cells (CAR-T cells) and human tissues grown on scaffolds

Arch Therapeutics liquid device stops bleeding immediately

Arch Therapeutics has developed a technology it says is able to control bleeding and leakage during surgery and trauma. The technology, known as the AC5 surgical hemostatic device, is able to stop bleeding immediately, with a elapsed time of 10 seconds. Other methods of hemostasis take anywhere between 180 and 300 seconds. Dr. Terrence Norchi,

Paper pump powers microfluidic devices for less than a dime

North Carolina researchers have developed a pump that powers microfluidic devices using paper. The inexpensive paper pump – developed by researchers at  North Carolina State University and the University of North Carolina at Chapel Hill – uses capillary actions to power portable microfluidic devices, which control fluids of 1 ml or less volume. “One longstanding

Here’s how you heat up cold hearts—for transplantation

A University of Minnesota–led research team has successfully warmed large-scale animal heart valves and blood vessels that were previously preserved at low temperatures. The discovery of this rewarming process is pivotal for organs and tissues that are left in storage for transplantation for extended periods. “This is the first time that anyone has been able

New blood-based test could detect all lung cancer types

Exact Sciences and the Mayo Clinic recently collaborated on a blood-based lung cancer test that researchers say has shown high accuracy for detecting all stages of lung cancer. “These results reveal an opportunity to detect lung cancer from a simple blood draw,” said Kevin Conroy, chairman and CEO of Exact Sciences, in a news release.